Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron vs Domperidone for Pediatric Vomiting in Acute Gastroenteritis
NCT05076461Completed
- Sponsor
- Tehsil Headquarter Hospital
- Start
- Jul 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ondansetron and domperidone in acute gastroenteritis and Vomiting, sponsored by Tehsil Headquarter Hospital. Primary endpoint: Cessation of vomiting at 24 hours. Started Jul 2020; status: completed.
02
Drugs
ondansetrondomperidone
03
Conditions
acute gastroenteritisVomiting
Beyond the preview
Go deeper on NCT05076461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05076461.